Thoorens Gregory, Krier Fabrice, Leclercq Bruno, Carlin Brian, Evrard Brigitte
Laboratory of Pharmaceutical Technology, Department of Pharmacy, C.I.R.M., University of Liège, 4000 Liège, Belgium; FMC Health and Nutrition, Brussels, Belgium.
Laboratory of Pharmaceutical Technology, Department of Pharmacy, C.I.R.M., University of Liège, 4000 Liège, Belgium.
Int J Pharm. 2014 Oct 1;473(1-2):64-72. doi: 10.1016/j.ijpharm.2014.06.055. Epub 2014 Jun 30.
The ICH quality vision introduced the concept of quality by design (QbD), which requires a greater understanding of the raw material attributes, of process parameters, of their variability and their interactions. Microcrystalline cellulose (MCC) is one of the most important tableting excipients thanks to its outstanding dry binding properties, enabling the manufacture of tablets by direct compression (DC). DC remains the most economical technique to produce large batches of tablets, however its efficacy is directly impacted by the raw material attributes. Therefore excipients' variability and their impact on drug product performance need to be thoroughly understood. To help with this process, this review article gathers prior knowledge on MCC, focuses on its use in DC and lists some of its potential critical material attributes (CMAs).
国际人用药品注册技术协调会(ICH)的质量愿景引入了质量源于设计(QbD)的概念,这需要对原材料属性、工艺参数、其变异性及其相互作用有更深入的了解。微晶纤维素(MCC)是最重要的片剂辅料之一,因其出色的干粘合性能,能够通过直接压片(DC)制造片剂。直接压片仍然是生产大批量片剂最经济的技术,然而其效果直接受到原材料属性的影响。因此,辅料的变异性及其对药品性能的影响需要被透彻理解。为了辅助这一过程,这篇综述文章收集了关于微晶纤维素的先前知识,重点关注其在直接压片中的应用,并列出了一些其潜在的关键物料属性(CMA)。